A carregar...
A case report of endorectal displacement of a right ureteral stent following radiochemotherapy and Bevacizumab
BACKGROUND: The angiogenesis inhibitor monoclonal antibody Bevacizumab is presently the standard treatment for numerous neoplasms but particular toxicities are emerging, such as hypertension, haemorrhage, thromboembolism, gastrointestinal perforation, fistulae, and delayed wound healing. The additio...
Na minha lista:
| Publicado no: | BMC Urol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6902463/ https://ncbi.nlm.nih.gov/pubmed/31818277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-019-0566-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|